Detalhe da pesquisa
1.
The influence of body mass index and age on C-peptide at the diagnosis of type 1 diabetes in children who participated in the diabetes prevention trial-type 1.
Pediatr Diabetes;
19(3): 403-409, 2018 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29171129
2.
Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials.
Diabetes;
69(8): 1827-1832, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32439823
3.
Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention.
Diabetes Care;
42(12): 2228-2236, 2019 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31558546
4.
Type 1 Diabetes TrialNet: A Multifaceted Approach to Bringing Disease-Modifying Therapy to Clinical Use in Type 1 Diabetes.
Diabetes Care;
41(4): 653-661, 2018 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29559451
5.
Use of Dried Capillary Blood Sampling for Islet Autoantibody Screening in Relatives: A Feasibility Study.
Diabetes Technol Ther;
17(12): 867-71, 2015 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26375197
6.
A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history.
Diabetes Care;
38(2): 271-6, 2015 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25519451
7.
The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 months.
Diabetes Care;
38(5): 940-2, 2015 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25758770
8.
Erratum. Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention. Diabetes Care 2019;42:2228-2236.
Diabetes Care;
43(4): 934, 2020 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32132004
9.
Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for improving the accuracy of the risk classification of type 1 diabetes.
Diabetes Care;
37(4): 979-84, 2014 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24550217
10.
Erratum. Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study. Diabetes Care 2011;34:1785-1787.
Diabetes Care;
41(4): 913, 2018 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29475842
11.
Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants.
Diabetes;
62(12): 4179-83, 2013 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23863814
12.
The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetes.
Diabetes Care;
35(7): 1552-5, 2012 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22547092
13.
Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study.
Diabetes Care;
34(8): 1785-7, 2011 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21680724
14.
Trends of earlier and later responses of C-peptide to oral glucose challenges with progression to type 1 diabetes in diabetes prevention trial-type 1 participants.
Diabetes Care;
33(3): 620-5, 2010 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20032282
15.
Glucose excursions between states of glycemia with progression to type 1 diabetes in the diabetes prevention trial-type 1 (DPT-1).
Diabetes;
59(10): 2386-9, 2010 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20682683